450 related articles for article (PubMed ID: 31076418)
1. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.
Gordin D; Shah H; Shinjo T; St-Louis R; Qi W; Park K; Paniagua SM; Pober DM; Wu IH; Bahnam V; Brissett MJ; Tinsley LJ; Dreyfuss JM; Pan H; Dong Y; Niewczas MA; Amenta P; Sadowski T; Kannt A; Keenan HA; King GL
Diabetes Care; 2019 Jul; 42(7):1263-1273. PubMed ID: 31076418
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.
Qi W; Keenan HA; Li Q; Ishikado A; Kannt A; Sadowski T; Yorek MA; Wu IH; Lockhart S; Coppey LJ; Pfenninger A; Liew CW; Qiang G; Burkart AM; Hastings S; Pober D; Cahill C; Niewczas MA; Israelsen WJ; Tinsley L; Stillman IE; Amenta PS; Feener EP; Vander Heiden MG; Stanton RC; King GL
Nat Med; 2017 Jun; 23(6):753-762. PubMed ID: 28436957
[TBL] [Abstract][Full Text] [Related]
3. Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism.
Qi W; Li Q; Gordin D; King GL
J Mol Med (Berl); 2018 May; 96(5):373-381. PubMed ID: 29574544
[TBL] [Abstract][Full Text] [Related]
4. Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy.
Fu J; Shinjo T; Li Q; St-Louis R; Park K; Yu MG; Yokomizo H; Simao F; Huang Q; Wu IH; King GL
JCI Insight; 2022 Mar; 7(5):. PubMed ID: 35133981
[TBL] [Abstract][Full Text] [Related]
5. Gene Regulatory Effect of Pyruvate Kinase M2 is Involved in Renal Inflammation in Type 2 Diabetic Nephropathy.
Li L; Tang L; Yang X; Chen R; Zhang Z; Leng Y; Chen AF
Exp Clin Endocrinol Diabetes; 2020 Sep; 128(9):599-606. PubMed ID: 31958846
[TBL] [Abstract][Full Text] [Related]
6. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
Shahni R; Gnudi L; King A; Jones P; Malik AN
Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
[TBL] [Abstract][Full Text] [Related]
8. Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.
Kubota M; Watanabe R; Yamaguchi M; Hosojima M; Saito A; Fujii M; Fujimura S; Kadowaki M
Br J Nutr; 2016 Oct; 116(8):1326-1335. PubMed ID: 27724997
[TBL] [Abstract][Full Text] [Related]
9. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy.
Wijkström J; González-Quiroz M; Hernandez M; Trujillo Z; Hultenby K; Ring A; Söderberg M; Aragón A; Elinder CG; Wernerson A
Am J Kidney Dis; 2017 May; 69(5):626-636. PubMed ID: 28126239
[TBL] [Abstract][Full Text] [Related]
10. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
[TBL] [Abstract][Full Text] [Related]
11. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes.
Viazzi F; Piscitelli P; Giorda C; Ceriello A; Genovese S; Russo GT; Fioretto P; Guida P; De Cosmo S; Pontremoli R;
J Diabetes Complications; 2017 Feb; 31(2):419-426. PubMed ID: 27884661
[TBL] [Abstract][Full Text] [Related]
12. Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes.
Hernandez SL; Gong JH; Chen L; Wu IH; Sun JK; Keenan HA; King GL
Diabetes Care; 2014 Aug; 37(8):2193-201. PubMed ID: 24780357
[TBL] [Abstract][Full Text] [Related]
13. Glycolytic lactate in diabetic kidney disease.
Darshi M; Kugathasan L; Maity S; Sridhar VS; Fernandez R; Limonte CP; Grajeda BI; Saliba A; Zhang G; Drel VR; Kim JJ; Montellano R; Tumova J; Montemayor D; Wang Z; Liu JJ; Wang J; Perkins BA; Lytvyn Y; Natarajan L; Lim SC; Feldman H; Toto R; Sedor JR; Patel J; Waikar SS; Brown J; Osman Y; He J; Chen J; Reeves WB; de Boer IH; Roy S; Vallon V; Hallan S; Gelfond JA; Cherney DZ; Sharma K;
JCI Insight; 2024 Jun; 9(11):. PubMed ID: 38855868
[TBL] [Abstract][Full Text] [Related]
14. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
15. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
[TBL] [Abstract][Full Text] [Related]
16. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
Pena MJ; Heinzel A; Heinze G; Alkhalaf A; Bakker SJ; Nguyen TQ; Goldschmeding R; Bilo HJ; Perco P; Mayer B; de Zeeuw D; Lambers Heerspink HJ
PLoS One; 2015; 10(5):e0120995. PubMed ID: 25973922
[TBL] [Abstract][Full Text] [Related]
17. Urine Tricarboxylic Acid Cycle Metabolites Predict Progressive Chronic Kidney Disease in Type 2 Diabetes.
Liu JJ; Liu S; Gurung RL; Ching J; Kovalik JP; Tan TY; Lim SC
J Clin Endocrinol Metab; 2018 Dec; 103(12):4357-4364. PubMed ID: 30060124
[TBL] [Abstract][Full Text] [Related]
18. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
[TBL] [Abstract][Full Text] [Related]
19. Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg Diabetes Register.
Pikkemaat M; Melander O; Bengtsson Boström K
J Diabetes Complications; 2015; 29(8):1062-5. PubMed ID: 26321369
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.
Sharma K; Karl B; Mathew AV; Gangoiti JA; Wassel CL; Saito R; Pu M; Sharma S; You YH; Wang L; Diamond-Stanic M; Lindenmeyer MT; Forsblom C; Wu W; Ix JH; Ideker T; Kopp JB; Nigam SK; Cohen CD; Groop PH; Barshop BA; Natarajan L; Nyhan WL; Naviaux RK
J Am Soc Nephrol; 2013 Nov; 24(11):1901-12. PubMed ID: 23949796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
